Moreover, this study was the first to validate the differential expression of ARPC5 in HCC tissues and explore the role of ARPC5 in the proliferation, apoptosis, and invasion of HCC cells, which provided a preliminary foundation for the development of biomarker-targeting therapies in HCC. This evidence concerns the gene ARPC5 and hepatocellular carcinoma.